Market Access Analytics and Insight
Our Market Research & Analysis service is uniquely tailored for the medical device & Life…
The incremental cost-effectiveness ratio is the central output of most cost-effectiveness and cost-utility analyses, calculated as the difference in cost between two options divided by the difference in their effect, and commonly expressed as an additional cost per quality-adjusted life year gained. It represents the extra amount that must be paid to obtain an additional unit of health benefit by choosing one option over another, and it is compared against a cost-effectiveness threshold to judge whether that additional benefit is worth its additional cost. The ratio can be unstable or difficult to interpret when differences are very small or when an option is more effective and less costly, situations better handled by net-benefit measures. It is the metric HTA bodies most often use to summarise value for money, and understanding it is essential to constructing and communicating an economic case.
Our Services
NICE HTA Strategy and Submission
Navigate the complexities of NICE Health Technology Assessment (HTA) submissions with our expert strategic guidance.…
Health Economics and Outcomes Research (HEOR)
Specialising in economic modelling for the medical device and life sciences sectors, our HEOR service…
Strategy Development
Leading in market access, Strategy Development from Health Analytical Solutions moves beyond just market entry…
Reimbursement Strategy and Support
Reimbursement Support, tailored for the complex NHS landscape, aids medical device and life sciences companies…
NHS Drug Tariff Submission Support
Our NHS Drug Tariff Submission Service offers specialised expertise in health economics, crucial for navigating…
Private healthcare
Delivering a comprehensive analysis of the UK's private healthcare sector, the Private Healthcare Landscape service…
Value Proposition Development for MedTech
Unlock the potential of your MedTech innovation with our Value Proposition Development service. At Health…
Primary Care Market Insights
Unlock the potential of the primary care market with our in-depth Primary Care Market Insights…
Stakeholder Engagement for Health Technologies
In the complex ecosystem of healthcare, effectively engaging with key stakeholders is fundamental to the…
Sustainability and NET Zero for MedTech
In an era where sustainability is not just an option but a necessity, MedTech companies…
Evidence Generation and Management
In the MedTech sector, the value of an innovation is increasingly measured not just by…
Dashboard Tools for Market Access
Navigating the complexities of market access requires not just data, but insights that can drive…
MedTech Sales Team Empowerment
The UK's National Health Service (NHS) represents a unique and complex market for MedTech sales.…
NHS MedTech Business Case Formulation
Securing NHS adoption for MedTech innovations demands not just outstanding technology but also a compelling…
© Health Analytical Solutions 2026